Glucagon-like Peptide-1 Receptor Agonists and Glaucoma

In the September 2024 edition of the Journal Ophthalmology, Dr. Siar Niazi and colleagues published a study about glaucoma in patients with diabetes.

Glucagon-like peptide-1 receptor agonists include now famous medications such as Ozempic.

They compared the rate of developing glaucoma in people with diabetes who were on these medications to the rate of developing glaucoma in people with diabetes without the meds. They found that use of GLP-1RAs was associated with a lower risk of getting glaucoma.

Of course, these are preliminary data and not a controlled trial, but maybe we are adding to the list of magical things these medications might do!